Registration Header
REGISTER TODAY!

Anika Investor Day 2021

Date:6/3/2021

Start Time:9:00 AM EDT

Duration: ~180 minutes

Abstract:

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Please join us for our 2021 Virtual Investor Day to learn how Anika is transforming itself into a leading provider of orthopedic products for osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.

If you're already registered for the Anika Investor Day 2021 webcast, click below:

ALREADY REGISTERED?

Speakers

Cheryl Blanchard, Ph.D.

Anika

President and Chief Executive Officer

On April 26, 2020, Cheryl Blanchard, Ph.D. was appointed President and Chief Executive Officer, after serving as interim Chief Executive Officer since February 2020. Dr. Blanchard joined the Board of Directors of Anika Therapeutics, Inc. in August 2018. Prior to her work as an executive officer with Anika, she served as the President and Chief Executive Officer of Microchips Biotech, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products, from 2014 until its sale to Daré Bioscience, Inc. in November 2019. From 2012 to 2020, Dr. Blanchard has also been a Principal at Blanchard Consulting, LLC which provides scientific, regulatory, and business strategy consulting services to medical device companies and private equity clients. From 2000 to 2012, she served in various officer positions of Zimmer, Inc. (now Zimmer Biomet), a medical device company focused on musculoskeletal products, including as the Senior Vice President, Chief Scientific Officer, and general manager of Zimmer Biologics. She was also a member of Zimmer’s executive committee and founded, built and led Zimmer’s Joint Preservation/Regenerative Medicine business. Prior to joining Zimmer, Dr. Blanchard built and led the medical device practice at Southwest Research Institute. She has served as a director of Daré Bioscience, Inc. (NASDAQ: DARE), a publicly held leader in women’s health innovation, since November 2019. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering from the University of Texas at Austin and received her B.S. in Ceramic Engineering from Alfred University. Until her appointment as interim Chief Executive Officer, Dr. Blanchard served as a member of Anika’s Compensation Committee and Governance and Nominating Committee.

Michael Levitz

Executive Vice President, Chief Financial Officer and Treasurer

Anika

On August 10, 2020, Michael Levitz was appointed Executive Vice President, Chief Financial Officer and Treasurer. Prior to joining Anika, Mr. Levitz served as Senior Vice President, Chief Financial Officer and Treasurer of Insulet Corporation, a global innovative medical device and drug delivery company. From 2009 to 2015, he was the Senior Vice President, Chief Financial Officer and Treasurer of Analogic Corporation, a global provider of medical guidance, diagnostic imaging and threat detection equipment. Previously, during his seven years with Hologic, Inc. and Cytyc Corporation (which merged with Hologic in October 2007), Mr. Levitz served in various capacities including Vice President and Corporate Controller. He began his career in the high technology audit practice at Arthur Andersen LLP. In 2011, he was a finalist for the Boston Business Journal's Chief Financial Officer of the Year award. Mr. Levitz earned his Bachelor of Arts in Business Economics, with emphasis in Accounting, from the University of California Santa Barbara and is a certified public accountant

Ben Joseph

Vice President, US Commercial and Global Brand Management

Anika

Ben Joseph joined Anika in August 2020 from Mend Medical, a healthcare portfolio company of Ambassador Enterprises where he was President and General Manager. Mr. Joseph spent over 10 years at Zimmer Biomet in key positions in the Sports Medicine and the Extremities business segments. He has held roles including Director of US Commercialization and Director of Marketing. In his last role at Zimmer Biomet, Mr. Joseph was the General Manager of the Global Foot and Ankle Business, and key initiatives included portfolio rationalization, product development focus, re-branding, and the build-out of a specialized sales channel. Throughout his tenure at Zimmer Biomet, he had a track record of building excellent teams and delivering consistent top and bottom line growth. Mr. Joseph holds a B.S. in Business Management and an M.B.A. from the Indiana University Kelley School of Business.

Steven Ek

Vice President of Research and Development

Anika

On May 29, 2020, Steven Ek was appointed as Vice President of Research and Development. Steve joined Anika Therapeutics, Inc. in February of 2020 following the acquisition of Arthrosurface, Inc. Steve brings over 30 years of product development experience to Anika. Most recently, Mr. Ek had served as President and CEO of Arthrosurface, Inc., which he Co-Founded in 2002. Prior to this role, Steve held several senior level research and development and engineering roles at Smith & Nephew, CONMED Corp., and Primo Medical Group.

Steve holds a B.E. in Materials Science and Engineering from the University of Florida.

Kevin Stone

Vice President and General Manager of Sports Medicine

Anika

On February 1, 2021, Kevin Stone joined Anika as Vice President and General Manager of Sports Medicine. Kevin has over 30 years of experience in orthopedic device development and manufacturing with Zimmer Biomet, and previously Biomet, in roles such as Vice President of Emerging Technology and Innovation; Vice President and General Manager of Sports Medicine; and Vice President of Innovation for Sports Medicine, Extremities and Trauma. In addition to his extensive leadership experience, Kevin is a named Inventor on numerous US and foreign patents covering orthopedic devices in Sports Medicine, Joint Replacement, Trauma, Biologics, and Spine.

Kevin received his BS degree in Bioengineering from the University of Dayton and his MS degree in Bioengineering from Clemson University.

Dr. Wasik Ashraf

Director of the Sports Medicine Program

St Luke’s Cornwall Hospital

Dr. Ashraf is a Board Certified fellowship-trained orthopedic surgeon specializing in sports medicine, joint preservation, and cartilage restoration. Dr. Ashraf completed his residency in orthopedic surgery at the Northwell Hospital system, and his fellowship in sports medicine at the Hughston clinic in Columbus, Georgia. Currently, he practices in Orange County, New York and provides sports coverage to several local schools. He Is the Director of the Sports Medicine Program at St Luke’s Cornwall Hospital and spearheads the Opioid Sparing Surgery program in the community.
First Name
Last Name
Email Address
Company
Job Title
Country